Hisamitsu Pharmaceutical Co., Inc.
OTC: HTSUY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Kazuhide Nakatomi
- Employees
- 2,769
- Headquarters
- Tosu, Japan
- IPO year
- 2017
- Market cap
- $839.0M
- Website
- http://www.hisamitsu.co.jp
Loading HTSUY…
Loading profile data…Frequently asked questions about HTSUY
What does Hisamitsu Pharmaceutical Co., Inc. (HTSUY) do?
Hisamitsu Pharmaceutical Co., Inc. is a company dedicated to the entire lifecycle of healthcare products, from initial research and development to manufacturing and global distribution of pharmaceuticals and related health solutions. It is particularly recognized for its well-known brands such as Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Kep...
Where does HTSUY trade?
Hisamitsu Pharmaceutical Co., Inc. (HTSUY) trades on the Other OTC.
What sector is HTSUY in?
Hisamitsu Pharmaceutical Co., Inc. (HTSUY) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Hisamitsu Pharmaceutical Co., Inc.?
Kazuhide Nakatomi is the chief executive officer of Hisamitsu Pharmaceutical Co., Inc. (HTSUY).
Where is Hisamitsu Pharmaceutical Co., Inc. headquartered?
Hisamitsu Pharmaceutical Co., Inc. is headquartered in Japan.
Does HTSUY pay a dividend?
Yes — Hisamitsu Pharmaceutical Co., Inc. (HTSUY) paid a trailing twelve-month dividend of USD 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did HTSUY go public?
Hisamitsu Pharmaceutical Co., Inc. (HTSUY) completed its initial public offering in 2017.